Latest 20-F annual reports

Anheuser-Busch InBev SA/NV releases its 20-F filing, detailing financial results and key business activities for the fiscal year ended December 31, 2024.

Alpha Tau Medical's 2024 annual report details the company's financial status and ongoing clinical trials for its Alpha DaRT technology.

ZIM Integrated Shipping Services announces its financial results for the year ended December 31, 2024, showcasing key financial metrics and strategic operational updates.

Oculis Holding AG reports its financial results for the year ended December 31, 2024, highlighting key developments in its clinical programs and strategic initiatives.

Ericsson's 2024 Annual Report showcases the company's strategic focus on mobile network innovation, enterprise expansion, and commitment to integrity, alongside key financial metrics.

Polyrizon Ltd.'s 2024 annual report details the company's financial status, development plans for its C&C and T&T platforms, and risk factors impacting future performance.

Legend Biotech's 20-F filing highlights significant revenue growth driven by CARVYKTI sales, alongside ongoing investments in research and development.

Fidelis Insurance Holdings Limited announces its financial results for the year ended December 31, 2024, highlighting growth in gross premiums written and strategic capital allocation.

Viking Holdings Ltd's 20-F filing provides a comprehensive overview of the company's financial performance, strategic initiatives, and risk management in the global cruise industry.

Gauzy Ltd. amends and restates a warrant agreement with OIC Growth Gauzy Holdings, LLC, increasing the number of ordinary shares purchasable and adjusting terms.

Vertical Aerospace's 20-F filing reveals a year of strategic advancements alongside ongoing financial challenges and a shift in control to Mudrick Capital.

Dole PLC's 20-F filing highlights a year of strategic shifts, including the termination of the Fresh Express Agreement and ongoing efforts to exit the Fresh Vegetables business, amidst a complex global economic landscape.

Inspira Technologies' 2024 annual report details progress in regulatory approvals, product development, and strategic partnerships, while also addressing financial challenges and future growth strategies.

Safe Bulkers details its 2024 financial performance and strategic initiatives in its annual report, highlighting fleet management and response to industry challenges.

Purple Biotech files its 20-F, reporting financial results for the year ended December 31, 2024, and outlining progress in its clinical-stage oncology programs.

ArcelorMittal's 20-F filing highlights the company's financial performance, strategic initiatives, and commitment to sustainability in a challenging global environment.

Smith & Nephew's 2024 annual report highlights significant progress in operational and financial performance, driven by the company's 12-Point Plan, with revenue growth, improved profitability, and strong cash flow generation.

Cheer Holding introduces a new equity incentive plan to attract top talent and details its financial standing in its annual 20-F filing.

BioNTech SE files its annual report on Form 20-F, detailing the company's business, operations, and financial performance for the year ended December 31, 2024.

Kaspi.kz announces robust financial performance for FY2024, driven by growth across its Payments, Marketplace, and Fintech platforms.

Decent Holding Inc.'s annual report reveals a revenue increase for fiscal year 2024, but also identifies a material weakness in internal control over financial reporting.

WINS Finance Holdings Inc. files its 20-F for the fiscal year ended June 30, 2024, highlighting a shift towards medical equipment sales and away from financial leasing.

Amer Sports, Inc. releases its 20-F annual report, detailing its financial performance and key business activities for the fiscal year ended December 31, 2024.

Jumia Technologies AG announces its FY2024 financial results, highlighting a strategic shift towards profitability and efficiency.

Ardmore Shipping Corp files its 20-F, detailing its financial performance and operational activities for the year ended December 31, 2024.

Oncolytics Biotech Inc. announces its financial results for the year ended December 31, 2024, and provides an update on its clinical development programs and corporate activities.

Santander UK's 2024 annual report reveals a decrease in profit before tax, reflecting market-wide pressures on deposit costs and a charge for historical motor finance commission payments, while highlighting strategic investments in digital capabilities and sustainability initiatives.

ZOOZ Power Ltd. reports its 2024 financial results and outlines its strategic initiatives to accelerate the adoption of electric vehicles by expanding ultra-fast charging infrastructure.

C21 Investments Inc. amends its transition report to explicitly identify columnar headings and footnote disclosures for the two months ended March 31, 2024.

Stevanato Group's 20-F filing details the company's financial performance for fiscal year 2024, highlighting both growth and challenges in a dynamic market environment.